The 2025-26 Budget: Health Care Access and Information

Feb 20, 2025 - Under the contract, which extends through the end of 2026, the contractor is to sell the new over‑the‑counter naloxone nasal spray product at $24 for each twin pack. The product entered the market in May 2024.
https://lao.ca.gov/Publications/Report/4979

The 2025-26 California Spending Plan: Health

Oct 16, 2025 - In addition, the spending plan assumes Medi-Cal ends coverage of certain kinds of over-the-counter drugs, such as COVID-19 tests, vitamins, and antihistamines. The associated savings with this action are much smaller, at $3  million General Fund in 2025-26, rising to $6  million General Fund in subsequent years.
https://lao.ca.gov/Publications/Report/5075

The 2023-24 Budget: Health Workforce Budget Solutions

Feb 21, 2023 - Reductions to public health workforce initiatives could work counter to the state ’s broader efforts to bolster its public health system. The Legislature could weigh these potential impacts when evaluating proposed budget solutions.
https://lao.ca.gov/Publications/Report/4691

The 2023-24 Budget: Whole Child Model Expansion

May 5, 2023 - For example, to the extent the Legislature does not intend to further integrate CCS into managed care, approving an expansion of the Whole Child Model at this time could run counter to its policy plans.
https://lao.ca.gov/Publications/Report/4767

The 2018-19 Budget: Meeting Workforce Demand for Certified Nursing Assistants in Skilled Nursing Facilities

Apr 27, 2018 - It also works directly counter to the state ’s recent actions creating the Adult Education Block Grant (AEBG). In 2013 ‑14, the state began restructuring its adult education system to increase access for adult learners and improve coordination among adult schools and community colleges.
https://lao.ca.gov/Publications/Report/3815

The 2021-22 Budget: Analysis of the Medi-Cal Budget

Feb 16, 2021 - These three expansions are ( 1)  i ntroducing a new remote patient monitoring benefit as part of a larger package of telehealth reforms; ( 2)  a dding continuous glucose monitors as a benefit for Medi ‑Cal beneficiaries with Type I diabetes; and ( 3)  p ermanently reinstating coverage of over ‑the ‑counter cough and cold products, which currently are covered as a part of the state ’s temporary package of Medi ‑Cal pandemic response policies.
https://lao.ca.gov/Publications/Report/4373